68 / 134
AOAC INTERNATIONAL Stakeholder Panel on Agent Detection Assays
Working Group Sessions - February 4, 2015 (Day 2)
I.
Welcome and Introductions
Davenport opened the second day of SPADA proceedings and explained that since all were present
from the previous day’s SPADA meeting, all were welcome to participate in the working groups. To
sign up for specific working groups and stay engaged with them in the future, participants were
encouraged to sign up through AOAC’s working group sign up form
10
.
II.
VEE Working Group
Ostlund led the group in a discussion on the SMPR for VEE. The group agreed that the purpose of
this SMPR will be the detection of agents if there is an aerosol release. There was a discussion on
whether or not to develop one SMPR or two, one for confirmation and one for screening. The group
agreed to limit the scope of the working group to one SMPR applicable to the detection of known
human pathogenic strains of VEE, and possibly EEV and WEEV, in dry filters and or liquid samples
from aerosol collectors, with the preferential method being a field-deployable assay that can detect
specific viruses.
A draft version of the
Variola
SMPR was used as a starting point and the group continued to
progress through that template, adjusting it to fit VEE as needed. Definitions were reviewed and
Ostlund took the action to provide an adequate definition of
Venezuelan Equine
Encephalitis/Encephalomyelitis Virus.
AOAC took the action to incorporate the validation guidance
and introduction paragraphs into the VEE SMPR. The group concluded its revisions with the first
page of the template and agreed to continue progress by teleconference (attachment 1).
III.
SEB Working Group
Tallent led the group in a discussion on the SMPR for SEB. Applicability was agreed as specific
detection of SEA, SEB, and SEC
dry filters and/or liquid samples from aerosol collectors,
with the
preference of a field deployable assay. The first page of the template SMPR was reviewed and
Tallent took the action to provide a definition of SEA-C for the definitions section. A lengthy
discussion ensued regarding the Acceptable Minimum Detection Level (AMDL) for SEB. The group
tentatively agreed to an AMDL of
25 ng / mL., but also agreed to revisit this issue once more data is
available. Johns took the action to research this and bring it back to the next meeting of the SEB
Working Group.
IV.
Q-Fever Working Group
10
AOAC SPADA Working Group Sign Up:
https://adobeformscentral.com/?f=Wwp88CLBMHw7QQ4Cr02L4g